Today, we hosted our very first in-house press conference, where we were thrilled to share not only our latest news but also our vision of how expertly combining Quantum Computing, HPC, and AI/ML will drastically improve the in silico drug discovery process by introducing even more precision, speed, and efficiency into our calculations. We'd like to extend our gratitude to: ▶ Robert Marino, CEO at Qubit Pharmaceuticals, for sharing the current state of how these technologies integrate into today's drug discovery process. ▶ Christophe Jurczak, Managing Partner at Quantonation, for providing valuable insights into the quantum ecosystem from an investor's perspective. ▶ Sébastien Luttringer, Head of R&D at Scaleway, for presenting their current activities as one of Europe's leading cloud providers and their strategy on quantum computing, which has supported us in some of our latest projects. ▶ Jean-Philip Piquemal, our CSO and Director of the Laboratoire de Chimie Théorique at Sorbonne Université, for explaining our latest achievements with Hyperion-1 and the new qubit compression techniques he and his team have developed. It was a morning full of information and learning, and we feel energized by the interest we've received! #QuantumComputing #HPC #AI #DrugDiscovery #QubitPharmaceuticals #Innovation #PressConference Ulysse Communication Nicolas Daniels Eléonore de Rose James Martin Sarada Loock photo credit © Choukhri Dje
-
+4
Delighted to have been a part of this event & to be helping Qubit Pharmaceuticals make its amazing strides in medical research! Thx, JM cc Sébastien Luttringer
Looking forward to this!
Well done!
Exciting!
Head of Marketing & Communications @ Qubit Pharmaceuticals
3moThanks for everyone who attended and presented!